Breast cancer has been the number one killer of women in recent times. One in eight women will be diagnosed with breast cancer in her lifetime. The disease which cuts across age, race, and class has killed so many of its victims and treatment is often very expensive.
While there is still no cure for breast cancer, researchers made three great advances towards eliminating the killer disease this year.
Here are three dramatic advances that are leading to more effective treatments, as well as brand new ways to think about what causes the deadly disease.
Targeted combo therapy completely obliterates signs of cancer
The biggest advance of 2016 in breast cancer has to be how a combination of targeted cancer drugs completely obliterated all signs of breast cancer in 11% of patients in only 11 days. The UK-based study involved 257 women with particularly virulent type of breast cancer (HER2-positive), and combined two drugs from GlaxoSmithKline and Roche Holdings
While 11% may not seem that impressive, for even one breast cancer tumor to be completely eradicated by a drug in less than two weeks is electrifying. Cancer tumors develop resistance to chemotherapy agents so rapidly, these drugs often have no impact on a tumor even after many months of treatment. Instead, tumors are removed surgically first. Chemotherapy comes afterward — to mop up stray cancer cells that might have spread elsewhere in the body. Read more